Literature DB >> 17240502

Intrusive thoughts, obsessions, and appraisals in obsessive-compulsive disorder: a critical review.

Dominic Julien1, Kieron P O'Connor, Frederick Aardema.   

Abstract

This article reviews empirical findings on two key premises of the appraisal model of obsessive-compulsive disorder (OCD): (a) non-clinical populations experience intrusive thoughts (ITs) that are similar in form and in content to obsessions; and (b) ITs develop into obsessions because they are appraised according to dysfunctional beliefs. There is support for the universality of ITs. However, the samples used are not representative of the general population. IT measures do not relate systematically or exclusively to OCD symptom measures, and are not specific enough to exclude other types of intrusive thoughts such as negative automatic thoughts or worries, nor are they representative of all types of obsessions. When general distress is controlled, there is so far no evidence that participants with OCD endorse obsessive belief domains more strongly than anxious participants, and inconclusive evidence that OCD and non-clinical samples differ on the belief domains. Some OCD symptom subtypes are associated with belief domains. Currently, there is no coherent model to offer strong predictions about the specificity of the empirically derived belief domains in OCD symptom subtypes. Cognitive therapy based on the appraisal model is an effective treatment for OCD, although it does not add to the treatment efficacy of behaviour therapy. It is unclear how appraisals turn ITs into obsessions. Implications for future research are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17240502     DOI: 10.1016/j.cpr.2006.12.004

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  9 in total

1.  A Novel Measure of Real-Time Perseverative Thought.

Authors:  Elizabeth C Wade; Rivka T Cohen; Paddy Loftus; Ayelet Meron Ruscio
Journal:  Clin Psychol Sci       Date:  2021-08-31

2.  Exam-related unwanted intrusive thoughts and related neutralizing behaviors: Analogues to obsessions and compulsions.

Authors:  Martin Kollárik; Carlotta V Heinzel; Marcel Miché; Roselind Lieb; Karina Wahl
Journal:  PLoS One       Date:  2022-07-05       Impact factor: 3.752

3.  Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions.

Authors:  Miguel A Fullana; David Mataix-Cols; Avshalom Caspi; Honalee Harrington; Jessica R Grisham; Terrie E Moffitt; Richie Poulton
Journal:  Am J Psychiatry       Date:  2009-02-02       Impact factor: 18.112

4.  The neural basis of unwanted thoughts during resting state.

Authors:  Simone Kühn; Marie-Anne Vanderhasselt; Rudi De Raedt; Jürgen Gallinat
Journal:  Soc Cogn Affect Neurosci       Date:  2013-08-07       Impact factor: 3.436

5.  Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.

Authors:  Marcella Curone; V Tullo; M Savino; A Proietti-Cecchini; G Bussone; D D'Amico
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

6.  The neural representation of intrusive thoughts.

Authors:  Simone Kühn; Florian Schmiedek; Annette Brose; Björn H Schott; Ulman Lindenberger; Martin Lövden
Journal:  Soc Cogn Affect Neurosci       Date:  2012-05-03       Impact factor: 3.436

7.  Dimensionality Analysis of the Thought Suppression Inventory: Combining EFA, MSA, and CFA.

Authors:  Andreas A J Wismeijer
Journal:  J Psychopathol Behav Assess       Date:  2011-08-12

8.  A Cross-Sectional Study on Cognitive Errors and Obsessive-Compulsive Disorders among Young People During the Outbreak of Coronavirus Disease 2019.

Authors:  Elham Darvishi; Solmaz Golestan; Farangis Demehri; Sheida Jamalnia
Journal:  Act Nerv Super (2007)       Date:  2020-10-31

Review 9.  Corticostriatal circuitry in regulating diseases characterized by intrusive thinking.

Authors:  Benjamin C Kalivas; Peter W Kalivas
Journal:  Dialogues Clin Neurosci       Date:  2016-03       Impact factor: 5.986

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.